98%
921
2 minutes
20
Background: Cognitive impairment in Parkinson's disease (PD) is a well-established non-motor complication that significantly affects the quality of life and well-being of both patients and care partners. To optimally detect mild cognitive impairment or dementia, extensive neuropsychological assessment is essential. A wide range of cognitive tests and clinical outcome assessments have been used in clinical settings, often without regard to their clinimetric quality.
Methods: We performed a literature review of tests assessing attention/working memory and executive domains in PD (tests on other domains are included in an accompanying review). The selected tests were evaluated for their clinimetric properties and categorized by a panel of experts as "recommended," "recommended with caveats," "suggested," or "listed" according to the International Parkinson and Movement Disorder Society Clinical Outcome Assessment Scientific Evaluation Committee guidelines.
Results: A total of 30 tests were reviewed. Eight tests were "recommended," including four tests assessing attention/working memory abilities (WAIS-IV Digit Span, Coding and Symbol Search subtests, and Trail Making Test) and four tests assessing executive abilities (WAIS-IV Similarities, Wisconsin Card Sorting Test, Fluency Tests, and Stroop Color-Word Test). These tests demonstrated good to excellent levels of reliability and validity, have normative datasets, and are sensitive to change. Eight other tests were "recommended with caveats", eleven were "suggested," and three were "listed."
Conclusions: The recommended tests for attention/working memory and executive functioning in PD can guide PD cognitive assessment. Other tests were identified as potentially useful; however, caution is advised due to their clinimetric limitations. Further validation studies are required for these tests. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mds.30293 | DOI Listing |
J Int Neuropsychol Soc
August 2025
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Objective: We investigated differences in cognition between variants of progressive supranuclear palsy (PSP) including PSP-Richardson (PSP-RS) and subcortical and cortical variants using updated diagnostic criteria and comprehensive neuropsychological assessment.
Method: We recruited 140 participants with PSP (age = 71.3 ± 6.
Psychiatry Investig
August 2025
Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea.
Objective: The superior longitudinal fasciculus (SLF) is a white matter (WM) bundle connecting the frontal and parietal lobes. SLF subdivisions have distinct functions (e.g.
View Article and Find Full Text PDFFront Psychol
July 2025
College of Physical Education and Training, Capital University of Physical Education and Sports, Beijing, China.
Objective: Physical exercise holds promise for improving cognitive function development in adolescents. However, current research evidence remains inconsistent. This systematic review and meta-analysis primarily aimed to determine the overall impact of physical exercise interventions on adolescent cognitive function.
View Article and Find Full Text PDFJ Cancer Surviv
August 2025
Department of Kinesiology and Nutrition, UIC, Chicago, IL, USA.
Background/objectives: Up to 75% of cancer survivors experience cognitive impairment from cancer or its treatment. No modifiable risk factor has been identified; however, a Mediterranean Diet may be protective. We sought to determine if the relationship between cognitive performance and cancer survivorship depends on Mediterranean Diet adherence.
View Article and Find Full Text PDFCNS Neurosci Ther
August 2025
Department of Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Background: Respiration-related sleep disorders such as obstructive sleep apnea (OSA) are risk factors for mild cognitive impairment and age-related neurocognitive deficits. Nearly 60% of patients with OSA suffer from a variety of impaired cognitive functions, including attention, working memory, and episodic memory, and are susceptible to mood disorders such as depression and anxiety. However, it remains largely unexplored regarding the features of the electroencephalography (EEG) microstates of these patients and the potential association between the EEG microstates and the cognitive impairments.
View Article and Find Full Text PDF